Market Movers (8-K)
See all →NYSE
MAGN
Magnera CORPMagnera Corporation announced a record third quarter with net sales of $857 million and adjusted EBITDA of $99 million, driven by organic volume growth and synergy initiatives.
NYSE
MAGN
Magnera CORPMagnera Corporation announced its second quarter 2026 financial results, reporting net sales of $796 million and Adjusted EBITDA of $90 million, in line with expectations.
NYSE
MAGN
Magnera CORPMagnera Corporation's shareholders approved the election of nine directors, ratified Ernst & Young LLP as its auditor, and gave advisory approval to executive compensation at its 2026 Annual Meeting.
NYSE
MAGN
Magnera CORPMagnera Corporation announced strong first-quarter results, exceeding expectations with increased net sales and adjusted EBITDA, while reaffirming its fiscal year 2026 guidance.
Better than expected
NYSE
MAGN
Magnera CORPMagnera Corporation announced the appointment of Erin Maile as Executive Vice President, Chief Accounting Officer, effective February 2, 2026.
NYSE
MAGN
Magnera CORPMagnera Corporation announced the date for its 2026 annual shareholder meeting and key deadlines for shareholder proposals and director nominations.
Quarterly Earnings (10-Q)
See all →NYSE
MAGN
Magnera CORPMagnera Corporation's Q2 2026 Form 10-Q filing reveals a 2% increase in net sales to $857 million, though the company reported a net loss of $20 million.
NYSE
MAGN
Magnera CORPMagnera Corporation reported a 3% decrease in net sales for the second quarter of fiscal year 2026, but saw a significant improvement in operating income due to cost management and integration efficiencies.
NYSE
MAGN
Magnera CORPMagnera Corporation reported a significant increase in net sales and a return to operating income in its first fiscal quarter, despite ongoing net losses and internal control deficiencies.
Better than expected
NYSE
MAGN
Magnera CORPMagnera Corporation reported a net loss of $18 million for the quarter ended June 28, 2025, despite a 51% increase in net sales driven by the Glatfelter acquisition.
Capital raise
Worse than expected
NYSE
MAGN
Magnera CORPMagnera Corporation's Q2 2025 results reflect the impact of the Glatfelter acquisition and general market softness, leading to a net loss despite increased net sales.
Worse than expected
NYSE
MAGN
Magnera CORPMagnera Corporation's Q1 2025 results reflect the impact of the recent acquisition of Glatfelter, with increased net sales but also higher operating losses.
Worse than expected
Annual Reports (10-K)
NYSE
MAGN
Magnera CORPMagnera Corporation, formed from the Glatfelter merger, reported significantly increased net sales and operating income for fiscal 2025, but also an increased net loss and identified material weaknesses in internal financial controls.
Capital raise
Worse than expected
NYSE
MAGN
Magnera CORPGlatfelter Corporation's 2023 annual report details a year of strategic turnaround efforts, including portfolio optimization and cost reductions, alongside a significant merger announcement with Berry Global's HHNF segment.
Worse than expected
Insider Trading (Form 4)
See all →NYSE
MAGN
Magnera CORPMagnera Corp's EVP, GC & Corp Sec, Jill L. Urey, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
NYSE
MAGN
Magnera CORPMagnera Corp's EVP, GC & Corporate Secretary, Jill L. Urey, reported the exercise of Restricted Stock Units and subsequent sale of shares for tax withholding purposes.
NYSE
MAGN
Magnera CORPMagnera Corp awarded 1,869 Restricted Stock Units to EVP and Chief Accounting Officer Erin Maile, vesting over three years.
NYSE
MAGN
Magnera CORPMagnera Corp director Bruce Brown was granted 5,871 restricted stock units on November 14, 2025 as a prorated director equity award vesting in one year.
NYSE
MAGN
Magnera CORPDirector Kevin Fogarty received a prorated grant of 5,871 RSUs on November 14, 2025, vesting in one year to align director equity awards with the 2026 Annual Shareholder Meeting cycle.
NYSE
MAGN
Magnera CORPMagnera Corp director Michael S. Curless received a prorated grant of 5,871 RSUs on November 14, 2025 that vests in full on November 14, 2026 to align director awards with the 2026 Annual Shareholder Meeting.
Proxy Statements (Def-14A)
NYSE
MAGN
Magnera CORPMagnera Corporation has filed definitive additional proxy materials with the SEC, indicating further disclosures related to a shareholder vote.
NYSE
MAGN
Magnera CORPMagnera Corporation announces its 2026 Annual Meeting of Shareholders to elect directors, ratify auditors, and vote on executive compensation, reflecting its first fiscal year post-merger.
Worse than expected
NYSE
MAGN
Magnera CORPGlatfelter Corporation's proxy statement details proposals for the upcoming annual shareholder meeting, including director elections, auditor ratification, and executive compensation approval.
Worse than expected
Schedule 13G - Passive Investments
See all →NYSE
MAGN
Magnera CORPMorgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting a decrease in their beneficial ownership of Magnera Corp's common stock to below the 5% threshold.
NYSE
MAGN
Magnera CORPNewtyn Management, LLC has filed a Schedule 13G reporting beneficial ownership of 2,760,000 shares of Magnera Corporation common stock.
NYSE
MAGN
Magnera CORPSCHEDULE: Magnera Corp Stakeholder Filing
Madison Avenue International LP and affiliated entities report a 4.4% stake in Magnera Corporation as of March 31, 2026.
NYSE
MAGN
Magnera CORPMorgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amended Schedule 13G, reporting beneficial ownership of 5.3% of Magnera Corp's common stock as of March 31, 2026.
NYSE
MAGN
Magnera CORPThe Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in Magnera Corp following an internal realignment.
NYSE
MAGN
Magnera CORPAncora Advisors LLC has reported a 1.49% beneficial ownership stake in Magnera Corp's common stock as of December 31, 2025.